Skip to main content
Log in

A study on the route of 1-methylurate formation in theophylline metabolism

  • Published:
Image European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The the urinary excretion patterns of theophylline metabolites were studied in a subject on a routine, oral dose of 600 mg/day. The highest correlation was observed between the excretions of 1,3-dimethylurate and 1-methylurate (r=0.73±0.08). The poorest correlations were observed when the excretion of 1-methylxanthine was compared to those of 1-methylurate and 1,3-dimethylurate (r ≤0.55,P≥0.05). The difference in the quality of the correlations was not due to rate-limiting or class-specific carriers. The results suggested that 1-methylurate did not derive solely from 1-methylxanthine, implicating 1,3-dimethylurate as an alternative source. When the theophylline regimen was supplemented by a single dose of caffeine (4.80 mg/kg), the recovery of unaltered caffeine and the yield of metabolites arising from the primary 3-demethylation of caffeine (1-methylxanthine, 7-methylxanthine, 1-methylurate, 1,7-dimethylxanthine and 1,7-dimethylurate) were found to be unchanged. The lack of competition between caffeine and theophylline indicated that caffeine 3-demethylation and the demethylations of theophylline are not catalyzed by the same cytochrome P450 system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Grygiel J.J., Wing L.M.H., Farkas J., Birkett D.J. (1979): Effects of allopurinol on theophylline metabolism and clearance. Clin. Pharmacol. ther., 26, 660–667.

    CAS  PubMed  Google Scholar 

  2. Jonkman J.H.G., Sollie F.A.E., Sauter R., Steinijans V.W. (1991): The influence of caffeine on steady-state pharmacokinetics of theophylline. Clin. Pharmacol. Ther., 49, 248–255.

    CAS  PubMed  Google Scholar 

  3. Gu L. Gonzalez F.J., Kalow W., Tang B.K. (1992): Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics, 2, 73–77.

    Article  CAS  PubMed  Google Scholar 

  4. Birkett D.J., Miners J.O., Day R.O. (1991): I-Methylxanthine derived from theophylline as an in vivo biochemical probe of allopurinol effect. Br. J. Clin. Pharmacol., 32, 238–241.

    CAS  PubMed  Google Scholar 

  5. Antal E.J., Kramer P.A., Mercik S.A., Chapron D.J., Lawson J.R. (1981): Theophylline pharmacokinetics in advanced age. Br. J. Clin. Pharmacol., 12, 637–645.

    CAS  PubMed  Google Scholar 

  6. Birkett D.J., Miners J.O., Atwood J. (1983): Secondary metabolism of theophylline biotransformation products in man — route of formation of 1-methyluric acid. Br. J. Clin. Pharmacol., 15, 117–119.

    CAS  PubMed  Google Scholar 

  7. Robson R.A., Matthews A.P., Miners J.O. et al. (1987): Characterization of theophylline metabolism in human liver microsomes. Br. J. Clin. Pharmacol., 24, 293–300.

    CAS  PubMed  Google Scholar 

  8. Sarkar M.A., Hunt C., Guzelian P.S., Karnes H.T. (1992): Characterization of human liver cytochrome P-450 involved in theophylline metabolism. Drug. Metab. Dispos., 20, 31–37.

    CAS  PubMed  Google Scholar 

  9. Grant D.M., Tang B.K., Kalow W. (1983): Variability in caffeine metabolism. Clin. Pharmacol. Ther., 33, 591–602.

    CAS  PubMed  Google Scholar 

  10. Tang-Liu D.D.S., Williams R.L., Riegelman S. (1983): Disposition of caffeine and its metabolites in man. J. Pharmacol. Exp. Ther., 224, 180–185.

    CAS  PubMed  Google Scholar 

  11. McClure W.R. (1969): A kinetic analysis of coupled enzyme assays. Biochemistry, 8, 2782–2786.

    Article  CAS  PubMed  Google Scholar 

  12. Lelo A., Kjellen G., Birkett D.J., Miners J.O. (1989): Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine. J. Pharmacol. Exp. Ther., 248, 315–319.

    CAS  PubMed  Google Scholar 

  13. Fuhr U., Doehmer J., Battula N. et al. (1993): Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolones. Toxicology, 82, 169–189.

    Article  CAS  PubMed  Google Scholar 

  14. Butler M.A., Iwasaki M, Guengerich F.P., Kadlubar F.F. (1989): Human cytochrome P450 pa (P-4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Biochemistry, 86, 7696–7670.

    CAS  Google Scholar 

  15. Berthou F., Finois J.P., Ratanasavanh D., Beaune P., Riche C., Guillozou A. (1991): Evidence for the involvement of several cytochromes P450 in the first steps of caffeine metabolism by human liver microsomes. Drug Metab. Dispos., 19, 561–567.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bayar, C., Özer, I. A study on the route of 1-methylurate formation in theophylline metabolism. Eur. J. Drug Metab. Pharmacokinet. 22, 415–419 (1997). https://doi.org/10.1007/BF03190979

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1007/BF03190979

Keywords